BOTOX: IT’S NOT JUST FOR WRINKLES     In 2002, the FDA approved the use of injected botulinum toxin type A for temporary reduction in the appearance of wrinkles between the eyebrows. It soon became apparent that the treatment was also effective at other sites and in 2013, the FDA approved its use for lines at the sides of the eyes (crow’s feet). In its 2014 compilation of usage and trends, the American Society of Plastic Surgeons reported that 6.6 million injections of botulinum toxin type A, better known as Botox (manufactured by Allergan), were performed that year.


+ There are no comments

Add yours